The company have invested more than $78 million in genomic science and genome sequencing technology over the last ten years.

LIC general manager NZ markets Malcolm Ellis said that when it comes to breeding, LIC’s investment in the long game has big benefits to farmers.

“Farmers appreciate the time lag of genetic gain between putting quality genetics into their herd and seeing the resulting benefits. But through sustained farmer shareholder investment and a wealth of genomics data we are delivering an increased rate of genetic gain within the bulls that arrive on farm each year,” Ellis said. 

He said that, coupled with good cows and a good herd, genomic science presents “a real opportunity” to shore up the herd’s efficiency. 

Ellis said that the company will continue to invest in research and development on behalf of its farmer shareholders. 

“As we invest more into the space, it is pleasing to see more and more farmers utilising genomic sires,” he said. 

LIC expects to complete 1.4 million genomic inseminations throughout New Zealand by the end of 2020.